PolyPeptide Group AG
SIX:PPGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Eolus Vind AB (publ)
STO:EOLU B
|
SE |
PolyPeptide Group AG
Revenue
PolyPeptide Group AG
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
PolyPeptide Group AG
SIX:PPGN
|
Revenue
€391.9m
|
CAGR 3-Years
11%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Bachem Holding AG
SIX:BANB
|
Revenue
CHf695.1m
|
CAGR 3-Years
9%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
|
Siegfried Holding AG
SIX:SFZN
|
Revenue
CHf1.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Lonza Group AG
SIX:LONN
|
Revenue
CHf6.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
|
|
Tecan Group AG
SIX:TECN
|
Revenue
CHf882.5m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
SKAN Group AG
SIX:SKAN
|
Revenue
CHf333.3m
|
CAGR 3-Years
6%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
PolyPeptide Group AG
Glance View
PolyPeptide Group AG is a contract development and manufacturing organization for clinical and approved commercial-stage peptide drug substances used in peptide-based therapeutics. The company is headquartered in Zug, Zug and currently employs 1,041 full-time employees. The company went IPO on 2021-04-29.
See Also
What is PolyPeptide Group AG's Revenue?
Revenue
391.9m
EUR
Based on the financial report for Dec 31, 2025, PolyPeptide Group AG's Revenue amounts to 391.9m EUR.
What is PolyPeptide Group AG's Revenue growth rate?
Revenue CAGR 5Y
12%
Over the last year, the Revenue growth was 16%. The average annual Revenue growth rates for PolyPeptide Group AG have been 11% over the past three years , 12% over the past five years .
